The challenge for gene therapy: innate immune response to adenoviruses
about
A short perspective on gene therapy: Clinical experience on gene therapy of gliomablastoma multiformeAnti-angiogenic gene therapy in the treatment of malignant gliomasThe role of chromatin in adenoviral vector functionSuppression of peritoneal tumorigenesis by placenta-derived mesenchymal stem cells expressing endostatin on colorectal cancer.Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.Production and characterization of novel recombinant adeno-associated virus replicative-form genomes: a eukaryotic source of DNA for gene transfer.Frizzled-7 promoter is highly active in tumors and promoter-driven Shiga-like toxin I inhibits hepatocellular carcinoma growth.First-in-class small molecule potentiators of cancer virotherapy.Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemiaInnate functions of immunoglobulin M lessen liver gene transfer with helper-dependent adenovirus.Adenovirus: the first effective in vivo gene delivery vectorAcute Respiratory Disease in US Army Trainees 3 Years after Reintroduction of Adenovirus Vaccine 1.Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death.Engineering protein self-assembling in protein-based nanomedicines for drug delivery and gene therapy.Adenoviruses types, cell receptors and local innate cytokines in adenovirus infection.Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?.Antitumor Efficacy of SLPI Promoter-Controlled Expression of Artificial microRNA Targeting EGFR in a Squamous Cell Carcinoma Cell Line.Adenovirus immunity: X marks the spot.Nano-sized calcium phosphate particles for periodontal gene therapy.Showing the Way: Oncolytic Adenoviruses as Chaperones of Immunostimulatory Adjuncts.
P2860
Q26849375-AD43BA32-7053-4D9B-BD4D-FC741ADCD62DQ26866276-18B36063-23F3-4D86-94AD-BBDC78C84316Q27004695-7A89BD90-BA3C-4667-949B-3958E7F236E6Q33843839-8FADCC73-CBF6-4042-BCB3-020321193BB7Q33881920-67D69490-7964-4716-A8B1-09783644477DQ34924696-E7277EF3-FE43-4D7F-B13B-668D847CC572Q36545508-C009BF94-EA14-455A-ADEC-2DAD22A9BCAAQ36937304-4437482A-83B3-4686-B900-A5C50916B47DQ37132233-1734B8B0-3D76-4A21-A150-8508F8EB5F8AQ37499424-6B76D7BF-4BB2-436F-9A0A-445170E504C6Q37508260-F6C54E24-01EC-4786-B589-B856E1C8E47CQ37524698-E951DF2A-CE9C-40CE-877E-14845E594D15Q37710422-D7FD36CF-73B9-42F1-A50A-15D5DFED039BQ38150365-5E41D6ED-7BF2-4743-B4A9-22B6A3CD9993Q38152792-A4134F51-B76D-4CA6-8879-D01AA97119BEQ38284700-6E1B32E0-8143-49BB-8E17-18964FA7E038Q38720608-21D7A80F-77B6-47E6-9386-82418F3D316CQ42407536-8686C7AE-A7B7-4AB0-9DC7-D99ACF9541C2Q42798305-4FE7D95C-1345-4708-98C6-B28CE8E82250Q53883435-ED1CB07D-1163-4FE6-BF90-EC53E2014B81
P2860
The challenge for gene therapy: innate immune response to adenoviruses
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The challenge for gene therapy: innate immune response to adenoviruses
@ast
The challenge for gene therapy: innate immune response to adenoviruses
@en
The challenge for gene therapy: innate immune response to adenoviruses
@nl
type
label
The challenge for gene therapy: innate immune response to adenoviruses
@ast
The challenge for gene therapy: innate immune response to adenoviruses
@en
The challenge for gene therapy: innate immune response to adenoviruses
@nl
prefLabel
The challenge for gene therapy: innate immune response to adenoviruses
@ast
The challenge for gene therapy: innate immune response to adenoviruses
@en
The challenge for gene therapy: innate immune response to adenoviruses
@nl
P2093
P2860
P921
P356
P1433
P1476
The challenge for gene therapy: innate immune response to adenoviruses
@en
P2093
Bart Thaci
Derek A Wainwright
Ilya V Ulasov
Maciej S Lesniak
P2860
P304
P356
10.18632/ONCOTARGET.231
P407
P577
2011-03-01T00:00:00Z